Article Text
Statistics from Altmetric.com
Recognising uncertainty is important in clinical practice, given the multiple levels of uncertainty around diagnosis, investigation and treatment. In clinical practice, the exact diagnosis can be uncertain. For example, do we know if a patient’s stroke is atheromatous, thromboembolic or has a rarer cause? In this issue, Robert Hurford et al help us disentangle the rarer causes of strokes, and how to recognise and investigate them (page 35). And given that almost all patients with cramps have no significant underlying disease, how can we recognise those that do? Jildou Dijkstra et al provide some answers to this on page 23.
There is often uncertainty over the best ways to investigate patients, particularly as newer tests become available. Katherine Shon and Patrick Chinnery propose a step change in investigation—moving directly to whole gene sequencing (page 2)—thereby rapidly diagnosing mitochondrial cytopathies. …
Read the full text or download the PDF:
Other content recommended for you
- A nationwide survey of combined central and peripheral demyelination in Japan
- Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal
- Application of the 2021 EAN/PNS criteria for chronic inflammatory demyelinating polyneuropathy
- Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy
- Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment
- Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review
- Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP
- Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy
- Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy
- Chronic inflammatory demyelinating polyneuropathy: a rare cause of falls